Liminatus Pharma Inc
LIMN
NASDAQ
Biotechnology
$0.14
USD
-0.01 (-6.60%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $7.86M
Volume 13.1M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
MTVA | MetaVia Inc | $9.45M | - | - | - | |
BIVI | BioVie Inc | $8.30M | - | - | - | |
LIMN | Liminatus Pharma Inc | $7.86M | - | - | - | |
CRIS | Curis Inc | $7.70M | - | -37.0% | - | |
BOLT | Bolt Biotherapeutics Inc | $7.67M | - | +78.6% | - | |
ALZN | Alzamend Neuro Inc | $7.00M | - | - | - | |
IMNN | Imunon Inc | $6.80M | - | - | - | |
ACXP | Acurx Pharmaceuticals Inc | $6.58M | - | - | - | |
FBLG | Fibrobiologics Inc | $6.53M | - | - | - | |
CELZ | Creative Medical Technology Holdings Inc | $5.69M | - | -78.6% | - |
Top Peer by Growth
Vistagen Therapeutics Inc
+15.3% YoY Revenue
Best 1-Year Return
Aprea Therapeutics Inc
-59.8% Return